ADVANCED NON-SMALL CELL SQUAMOUS LUNG CANCER
Clinical trials for ADVANCED NON-SMALL CELL SQUAMOUS LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED NON-SMALL CELL SQUAMOUS LUNG CANCER trials appear
Sign up with your email to follow new studies for ADVANCED NON-SMALL CELL SQUAMOUS LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets Tough-to-Treat cancers in brain and lungs
Disease control OngoingThis study is testing an oral medication called BDTX-1535 for adults with advanced non-small cell lung cancer or glioblastoma (a type of brain tumor) that have specific genetic changes. The goal is to find the safest and most effective dose and see if the drug can shrink tumors, …
Matched conditions: ADVANCED NON-SMALL CELL SQUAMOUS LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Black Diamond Therapeutics, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New drug targets advanced cancers in the brain
Disease control OngoingThis study is testing an experimental drug called HER3-DXd for patients whose cancer has spread to the brain or the lining of the spinal cord. It is for adults with advanced breast cancer, non-small cell lung cancer, or other solid tumors who have already tried at least one other…
Matched conditions: ADVANCED NON-SMALL CELL SQUAMOUS LUNG CANCER
Phase: PHASE2 • Sponsor: MedSIR • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Can your medical records replace a clinical trial?
Knowledge-focused OngoingThis study is not testing a new treatment. Instead, researchers are using existing electronic health records from over 800 lung cancer patients to see if they can accurately recreate the results of two past clinical trials. The goal is to understand when and how real-world patien…
Matched conditions: ADVANCED NON-SMALL CELL SQUAMOUS LUNG CANCER
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:17 UTC